oncology pharmaceuticals market in india 2014
TRANSCRIPT
www.MarketResearchReports.com
Oncology Pharmaceu
ticals Market in India 2014
Category : Pharma & Healthcare
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Introduction to Report
Launch Date: September 10, 2014
Number of Pages: 90
Geography Coverage: India
Available Format: PDF
Price For Single User License: USD 950
Price For Site User License: USD 1,425
Price For Global User License: USD 1,900
Delivery Time: Within 24 Hours (During Working Days)
www.MarketResearchReports.com
About the Report
Oncology Pharmaceutical Market in India 2014 report highlights the analysis of the drivers and explains the factors for growth of the industry.
Increasing number of cancer cases are the key drivers of this market. Lung, stomach, colon and breast cancer cause the maximum number of cancer deaths each year.
www.MarketResearchReports.com
Key Findings:
Pharmaceutical companies are progressively increasing R&D expenditure on cancer vaccines. The growing number of patients seeking treatment for cancer has made hospitals realize that cancer treatment is an important area for growth.
Gleevec, Mabthera, Iressa, Avastin, Grafeel, Soliris and Herceptin are the top selling cancer drugs in the Indian market.
Alternative therapies such as cancer gene therapy and cancer cell therapy are increasingly becoming popular in cases where conventional therapies have failed.
Combination therapies are being increasingly used in cancer treatments.
www.MarketResearchReports.com
Key Findings Continues…
Some challenges faced by the industry are the internal competition between large pharmaceutical companies.
Another challenge is the penetration of Oncological drugs in rural areas which is very low.
Various government initiatives have been undertaken to reduce the drug prices and various tax reforms and control programs are promoting the growth of the market as well.
www.MarketResearchReports.com
Key Findings Continues…
Manufacture of generic oncology drugs will help the pharmaceutical manufacturer gain a competitive advantage over others in a highly competitive pharma market.
Companies should focus on development of new molecules in order to prolong the longevity of a blockbuster drug in the market.
www.MarketResearchReports.com
Report Coverage
1. Executive Summary2. Introduction3. Market Overview4. Export-Import5. Value Chain6. Drivers & Challenges7. Government Initiatives8. Government Initiatives9. Regulations10. Competitive Landscape11. Recent Developments12. Strategic Recommendation13. Appendix
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Company Coverage
1. Sanofi India Ltd.2. Cipla Ltd.3. Dr. Reddy’s Laboratories Ltd.4. GlaxoSmithKline Pharmaceuticals Ltd.5. Novartis India Ltd.6. Merck Ltd.7. Pfizer Ltd.8. Ranbaxy Laboratories Ltd.9. Johnson and Johnson Ltd.10. Roche Pharmaceuticals Pvt. Ltd.
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Custom Research: Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research.
For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center
For regular industry updates subscribe to our newsletter at: http://www.marketresearchreports.com/subscribe-to-newsletter
www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and purchase this publication:
http://mrr.cm/4Zv
About Market Research Reports, Inc.Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”.
Contact : Amitava SenEmail : [email protected]: +1 302-703-7787 (USA) +91-8762746600 (India)